Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
evaluate the the dose-response of insulin detemir and insulin NPH in subjects with type 2
diabetes of various race and ethnicity.